Case Study: US Biotech Company achieves clearer European launch strategy with Evaluate

Analysis of European Launch Success Drivers for a US Biotech Planning its First EMA Filing

A US biotech company was planning its first product launch in Europe but had limited experience in those markets. This left them unsure of the optimal strategy and realistic revenue goals. The vendor, Evaluate, provided an analysis to address this challenge.

Evaluate delivered a data-driven assessment, offering quantitative and qualitative insights into value-drivers for comparable European product launches. The solution gave the client the necessary information to determine their commercialization approach and provided a checklist for their EMA filing. A key finding was the correlation between launch success and time to market.